Blockade of morphine-induced place preference by diazepam in mice

Tsutomu Suzuki, Tsuda Makoto, Masahiko Funada, Miwa Misawa

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The effects of diazepam on morphine-induced place preference were examined in mice. Pretreatment with diazepam (2 mg/kg i.p.) 30 min prior to morphine injection significantly abolished the morphine (5 mg/kg s.c.)-induced place preference, and this effect of diazepam was antagonized by pretreatment with flumazenil. In addition, pretreatment with diazepam prevented the morphine (5 mg/kg s.c.)-induced increase in dopamine turnover in the limbic forebrain. These results suggest that pretreatment with diazepam may suppress the rewarding effects of morphine.

Original languageEnglish
Pages (from-to)327-330
Number of pages4
JournalEuropean Journal of Pharmacology
Volume280
Issue number3
DOIs
Publication statusPublished - Jul 14 1995
Externally publishedYes

Fingerprint

Diazepam
Morphine
Flumazenil
Prosencephalon
Dopamine
Injections

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Blockade of morphine-induced place preference by diazepam in mice. / Suzuki, Tsutomu; Makoto, Tsuda; Funada, Masahiko; Misawa, Miwa.

In: European Journal of Pharmacology, Vol. 280, No. 3, 14.07.1995, p. 327-330.

Research output: Contribution to journalArticle

Suzuki, Tsutomu ; Makoto, Tsuda ; Funada, Masahiko ; Misawa, Miwa. / Blockade of morphine-induced place preference by diazepam in mice. In: European Journal of Pharmacology. 1995 ; Vol. 280, No. 3. pp. 327-330.
@article{f65013b7942b462882436c515a6b5b1f,
title = "Blockade of morphine-induced place preference by diazepam in mice",
abstract = "The effects of diazepam on morphine-induced place preference were examined in mice. Pretreatment with diazepam (2 mg/kg i.p.) 30 min prior to morphine injection significantly abolished the morphine (5 mg/kg s.c.)-induced place preference, and this effect of diazepam was antagonized by pretreatment with flumazenil. In addition, pretreatment with diazepam prevented the morphine (5 mg/kg s.c.)-induced increase in dopamine turnover in the limbic forebrain. These results suggest that pretreatment with diazepam may suppress the rewarding effects of morphine.",
author = "Tsutomu Suzuki and Tsuda Makoto and Masahiko Funada and Miwa Misawa",
year = "1995",
month = "7",
day = "14",
doi = "10.1016/0014-2999(95)00249-K",
language = "English",
volume = "280",
pages = "327--330",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Blockade of morphine-induced place preference by diazepam in mice

AU - Suzuki, Tsutomu

AU - Makoto, Tsuda

AU - Funada, Masahiko

AU - Misawa, Miwa

PY - 1995/7/14

Y1 - 1995/7/14

N2 - The effects of diazepam on morphine-induced place preference were examined in mice. Pretreatment with diazepam (2 mg/kg i.p.) 30 min prior to morphine injection significantly abolished the morphine (5 mg/kg s.c.)-induced place preference, and this effect of diazepam was antagonized by pretreatment with flumazenil. In addition, pretreatment with diazepam prevented the morphine (5 mg/kg s.c.)-induced increase in dopamine turnover in the limbic forebrain. These results suggest that pretreatment with diazepam may suppress the rewarding effects of morphine.

AB - The effects of diazepam on morphine-induced place preference were examined in mice. Pretreatment with diazepam (2 mg/kg i.p.) 30 min prior to morphine injection significantly abolished the morphine (5 mg/kg s.c.)-induced place preference, and this effect of diazepam was antagonized by pretreatment with flumazenil. In addition, pretreatment with diazepam prevented the morphine (5 mg/kg s.c.)-induced increase in dopamine turnover in the limbic forebrain. These results suggest that pretreatment with diazepam may suppress the rewarding effects of morphine.

UR - http://www.scopus.com/inward/record.url?scp=0029041348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029041348&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(95)00249-K

DO - 10.1016/0014-2999(95)00249-K

M3 - Article

C2 - 8566101

AN - SCOPUS:0029041348

VL - 280

SP - 327

EP - 330

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 3

ER -